Lataa...
Real world evidence on 5661 patients treated for macular oedema secondary to branch retinal vein occlusion with intravitreal anti-vascular endothelial growth factor, intravitreal dexamethasone or macular laser
BACKGROUND/AIMS: Clinical trials suggest anti-vascular endothelial growth factor is more effective than intravitreal dexamethasone as treatment for macular oedema secondary to branch retinal vein occlusion. This study asks if ‘real world’ data from a larger and more diverse population, followed for...
Tallennettuna:
| Julkaisussa: | Br J Ophthalmol |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMJ Publishing Group
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8005793/ https://ncbi.nlm.nih.gov/pubmed/32532760 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjophthalmol-2020-315836 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|